We are live on ! Find out more
HIM

Hermes Investment Management Portfolio holdings

AUM $7.52B
1-Year Est. Return 20.67%
This Fund
S&P 500
This Quarter Est. Return
+0.93%
1 Year Est. Return
+20.67%
3 Year Est. Return
+61.19%
5 Year Est. Return
+127.48%
10 Year Est. Return
AUM
$3.17B
AUM Growth
-$105M
Cap. Flow
-$106M
Cap. Flow %
-3.36%
Top 10 Hldgs %
18.22%
Holding
257
New
11
Increased
97
Reduced
65
Closed
9

Top Buys

Rank Stock Value
1
MCK icon
McKesson
MCK
+$37M
2
BIO icon
Bio-Rad Laboratories Class A
BIO
+$32.1M
3
GILD icon
Gilead Sciences
GILD
+$29.6M
4
LKQ icon
LKQ Corp
LKQ
+$14.1M
5
TSM icon
TSMC
TSM
+$11.1M

Sector Composition

Rank Sector Weight
1 Financials 19.34%
2 Industrials 16.51%
3 Consumer Discretionary 11.65%
4 Technology 10.65%
5 Healthcare 10.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BAC icon
101
Bank of America
BAC
$442B
$3.49M 0.11%
203,160
+37,760
+23% +$635K
VZ icon
102
Verizon
VZ
$196B
$3.42M 0.11%
71,927
+21,116
+42% +$999K
CVS icon
103
CVS Health
CVS
$122B
$3.26M 0.1%
43,566
+3,866
+10% +$273K
MPC icon
104
Marathon Petroleum
MPC
$83.7B
$3.21M 0.1%
73,642
+6,232
+9% +$273K
TRV icon
105
Travelers Companies
TRV
$80.2B
$3.2M 0.1%
37,629
+6,690
+22% +$562K
GE icon
106
GE Aerospace
GE
$384B
$3.17M 0.1%
25,593
+5,806
+29% +$717K
BIIB icon
107
Biogen
BIIB
$30.7B
$3.13M 0.1%
10,248
+541
+6% +$172K
WDC icon
108
Western Digital
WDC
$150B
$3.07M 0.1%
44,184
+6,361
+17% +$415K
TMO icon
109
Thermo Fisher Scientific
TMO
$220B
$3.06M 0.1%
25,418
+890
+4% +$106K
TSN icon
110
Tyson Foods
TSN
$20.4B
$3.02M 0.1%
68,500
+2,500
+4% +$94.7K
COF icon
111
Capital One
COF
$134B
$2.99M 0.09%
38,804
+1,196
+3% +$87.8K
PFE icon
112
Pfizer
PFE
$153B
$2.9M 0.09%
95,327
+5,634
+6% +$168K
STT icon
113
State Street
STT
$50.7B
$2.9M 0.09%
41,690
+6,290
+18% +$435K
MRK icon
114
Merck
MRK
$318B
$2.78M 0.09%
51,356
+19,914
+63% +$1.03M
BG icon
115
Bunge Global
BG
$20.8B
$2.72M 0.09%
34,249
+3,410
+11% +$268K
EMC
116
DELISTED
EMC CORPORATION
EMC
$2.67M 0.08%
97,604
-1,369,981
-93% -$35.6M
MET icon
117
MetLife
MET
$62.1B
$2.56M 0.08%
54,352
+10,907
+25% +$501K
DAL icon
118
Delta Air Lines
DAL
$60.1B
$2.51M 0.08%
72,413
+10,213
+16% +$328K
TT icon
119
Trane Technologies
TT
$106B
$2.42M 0.08%
42,257
+4,100
+11% +$244K
VTRS icon
120
Viatris
VTRS
$18.9B
$2.33M 0.07%
47,793
+3,400
+8% +$165K
TJX icon
121
TJX Companies
TJX
$178B
$2.31M 0.07%
76,268
-1,293,128
-94% -$39.2M
HUM icon
122
Humana
HUM
$46.2B
$2.17M 0.07%
19,260
+4,228
+28% +$440K
GIS icon
123
General Mills
GIS
$19.7B
$2.16M 0.07%
41,636
+3,483
+9% +$172K
SNDK
124
DELISTED
SANDISK CORP
SNDK
$2.14M 0.07%
26,355
+2,477
+10% +$183K
NBL
125
DELISTED
Noble Energy, Inc.
NBL
$2.08M 0.07%
29,290

Similar funds

Hermes Investment Management's Q1 2014 Portfolio in Review

As of Q1 2014, Hermes Investment Management held 257 positions worth $3.17B, down 3.2% from $3.28B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Hermes Investment Management withdrew a net $106M in Q1 2014, closing 9 positions and reducing 65 holdings. Its most notable exit was iShares MSCI All Country Asia ex Japan ETF, an estimated $71.4M position sold in full.

By sector, the portfolio is most concentrated in Financials at 19% of assets, up from 19% a quarter earlier, followed by Industrials and Consumer Discretionary.

Against the trend, Hermes Investment Management opened a new position in Bio-Rad Laboratories Class A worth $32.1M.

  • Hermes Investment Management's largest Q1 2014 buy was Bio-Rad Laboratories Class A: 250,414 shares worth $32.1M.
  • Hermes Investment Management added most to McKesson in Q1 2014, an estimated $37M increase.
  • Hermes Investment Management's biggest Q1 2014 reduction was TJX Companies, cutting an estimated $39.2M.
  • Hermes Investment Management fully exited iShares MSCI All Country Asia ex Japan ETF in Q1 2014, selling an estimated $71.4M.
  • Hermes Investment Management's ten largest holdings make up 18% of its $3.17B portfolio in Q1 2014.
  • Hermes Investment Management opened 11 new positions and closed 9 in Q1 2014.
  • Hermes Investment Management's portfolio value fell 3.2% quarter-over-quarter to $3.17B.

Based on Hermes Investment Management's 13F filing for Q1 2014, filed 13 May 2014.